Company Filing History:
Years Active: 2021-2023
Title: Andrea Natalizia: Innovator in Cardiac Ablation Technology
Introduction
Andrea Natalizia is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of cardiac health, particularly in the area of Brugada syndrome treatment. With a total of five patents to her name, Natalizia is recognized for her innovative approaches to analyzing and mapping ECG signals.
Latest Patents
One of her latest patents focuses on a system and method for Brugada syndrome epicardial ablation. This invention involves preparing an endocardial duration map and a baseline epicardial duration map that includes areas of delimination. When certain areas exceed 200 ms, the method allows for epicardial ablation of those areas. Furthermore, the process includes preparing an updated epicardial duration map post-ablation to determine the presence of a BrS pattern or abnormal EGM, guiding further ablation if necessary. This comprehensive approach aims to enhance the effectiveness of treatments for Brugada syndrome.
Career Highlights
Natalizia's career is marked by her dedication to advancing cardiac health technologies. She works at Biosense Webster Ltd., a company known for its innovative medical devices. Her work has been instrumental in developing methods that improve patient outcomes in cardiac care.
Collaborations
Throughout her career, Natalizia has collaborated with notable professionals in her field, including Carlo Pappone and Aharon Turgeman. These partnerships have contributed to her success and the advancement of her inventions.
Conclusion
Andrea Natalizia stands out as a leading inventor in the realm of cardiac ablation technology. Her innovative patents and commitment to improving treatment methods for Brugada syndrome highlight her significant impact on the medical field.